BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28699810)

  • 1. A balanced level of profilin-1 promotes stemness and tumor-initiating potential of breast cancer cells.
    Jiang C; Ding Z; Joy M; Chakraborty S; Kim SH; Bottcher R; Condeelis J; Singh S; Roy P
    Cell Cycle; 2017; 16(24):2366-2373. PubMed ID: 28699810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cells.
    Allen A; Gau D; Francoeur P; Sturm J; Wang Y; Martin R; Maranchie J; Duensing A; Kaczorowski A; Duensing S; Wu L; Lotze MT; Koes D; Storkus WJ; Roy P
    J Biol Chem; 2020 Nov; 295(46):15636-15649. PubMed ID: 32883810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profilin-1 downregulation has contrasting effects on early vs late steps of breast cancer metastasis.
    Ding Z; Joy M; Bhargava R; Gunsaulus M; Lakshman N; Miron-Mendoza M; Petroll M; Condeelis J; Wells A; Roy P
    Oncogene; 2014 Apr; 33(16):2065-74. PubMed ID: 23686314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profilin-1 overexpression upregulates PTEN and suppresses AKT activation in breast cancer cells.
    Das T; Bae YH; Wells A; Roy P
    J Cell Physiol; 2009 Feb; 218(2):436-43. PubMed ID: 18937284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profilin-1 is a negative regulator of mammary carcinoma aggressiveness.
    Zou L; Jaramillo M; Whaley D; Wells A; Panchapakesa V; Das T; Roy P
    Br J Cancer; 2007 Nov; 97(10):1361-71. PubMed ID: 17940506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of profilin-1 expression enhances breast cancer cell motility by Ena/VASP proteins.
    Bae YH; Ding Z; Zou L; Wells A; Gertler F; Roy P
    J Cell Physiol; 2009 May; 219(2):354-64. PubMed ID: 19115233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial morphological reversion drives Profilin-1-induced elevation of p27(kip1) in mesenchymal triple-negative human breast cancer cells through AMP-activated protein kinase activation.
    Jiang C; Veon W; Li H; Hallows KR; Roy P
    Cell Cycle; 2015; 14(18):2914-23. PubMed ID: 26176334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profilin-1 overexpression inhibits proliferation of MDA-MB-231 breast cancer cells partly through p27kip1 upregulation.
    Zou L; Ding Z; Roy P
    J Cell Physiol; 2010 Jun; 223(3):623-9. PubMed ID: 20143334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profilin-1 overexpression in MDA-MB-231 breast cancer cells is associated with alterations in proteomics biomarkers of cell proliferation, survival, and motility as revealed by global proteomics analyses.
    Coumans JV; Gau D; Poljak A; Wasinger V; Roy P; Moens PD
    OMICS; 2014 Dec; 18(12):778-91. PubMed ID: 25454514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axis.
    Yao W; Ji S; Qin Y; Yang J; Xu J; Zhang B; Xu W; Liu J; Shi S; Liu L; Liu C; Long J; Ni Q; Li M; Yu X
    Mol Cancer; 2014 Aug; 13():187. PubMed ID: 25103363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based virtual screening identifies a small-molecule inhibitor of the profilin 1-actin interaction.
    Gau D; Lewis T; McDermott L; Wipf P; Koes D; Roy P
    J Biol Chem; 2018 Feb; 293(7):2606-2616. PubMed ID: 29282288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of profilin1 function suppresses developmental and pathological retinal neovascularization.
    Gau D; Vignaud L; Allen A; Guo Z; Sahel J; Boone D; Koes D; Guillonneau X; Roy P
    J Biol Chem; 2020 Jul; 295(28):9618-9629. PubMed ID: 32444495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profilin-1 deficiency leads to SMAD3 upregulation and impaired 3D outgrowth of breast cancer cells.
    Chakraborty S; Jiang C; Gau D; Oddo M; Ding Z; Vollmer L; Joy M; Schiemann W; Stolz DB; Vogt A; Ghosh S; Roy P
    Br J Cancer; 2018 Oct; 119(9):1106-1117. PubMed ID: 30318519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profilin-1 overexpression restores adherens junctions in MDA-MB-231 breast cancer cells in R-cadherin-dependent manner.
    Zou L; Hazan R; Roy P
    Cell Motil Cytoskeleton; 2009 Dec; 66(12):1048-56. PubMed ID: 19593789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca2+ signaling in T24M-based bladder cancer models.
    Frantzi M; Klimou Z; Makridakis M; Zoidakis J; Latosinska A; Borràs DM; Janssen B; Giannopoulou I; Lygirou V; Lazaris AC; Anagnou NP; Mischak H; Roubelakis MG; Vlahou A
    Oncotarget; 2016 Oct; 7(43):70750-70768. PubMed ID: 27683119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing profilin-1 inhibits gastric cancer progression via integrin β1/focal adhesion kinase pathway modulation.
    Cheng YJ; Zhu ZX; Zhou JS; Hu ZQ; Zhang JP; Cai QP; Wang LH
    World J Gastroenterol; 2015 Feb; 21(8):2323-35. PubMed ID: 25741138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schlafen12 Reduces the Aggressiveness of Triple Negative Breast Cancer through Post-Transcriptional Regulation of ZEB1 That Drives Stem Cell Differentiation.
    Al-Marsoummi S; Vomhof-DeKrey E; Basson MD
    Cell Physiol Biochem; 2019; 53(6):999-1014. PubMed ID: 31838790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-Terminus of Hsc70-interacting protein regulates profilin1 and breast cancer cell migration.
    Choi YN; Lee SK; Seo TW; Lee JS; Yoo SJ
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1060-6. PubMed ID: 24661873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profilin 1 obtained by proteomic analysis in all-trans retinoic acid-treated hepatocarcinoma cell lines is involved in inhibition of cell proliferation and migration.
    Wu N; Zhang W; Yang Y; Liang YL; Wang LY; Jin JW; Cai XM; Zha XL
    Proteomics; 2006 Nov; 6(22):6095-106. PubMed ID: 17051635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Milk Protein Alpha-Casein Suppresses Triple Negative Breast Cancer Stem Cell Activity Via STAT and HIF-1alpha Signalling Pathways in Breast Cancer Cells and Fibroblasts.
    Garner KEL; Hull NJ; Sims AH; Lamb R; Clarke RB
    J Mammary Gland Biol Neoplasia; 2019 Sep; 24(3):245-256. PubMed ID: 31529195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.